Literature DB >> 17009243

Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.

Ursula Fearon1, Ronan Mullan, Trevor Markham, Mary Connolly, Shane Sullivan, A Robin Poole, Oliver FitzGerald, Barry Bresnihan, Douglas J Veale.   

Abstract

OBJECTIVE: To investigate the role of oncostatin M (OSM) in cell adhesion, angiogenesis, and matrix degradation in rheumatoid arthritis (RA) synovial tissue and normal human cartilage.
METHODS: Human dermal microvascular endothelial cell (HDMEC) and RA synovial fibroblast (RASF) proliferation and intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expression were assessed by a bromodeoxyuridine proliferation assay and flow cytometry. HDMEC tubule formation and migration were assessed by Matrigel culture and migration assay. Production of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinases 1 (TIMP-1) in RA synovial explants, and proteoglycan/glycosaminoglycan (GAG) release, vascular endothelial growth factor (VEGF), and angiopoietin 2 production from RASF/normal cartilage cocultures were assessed by enzyme-linked immunosorbent assay and immunohistology.
RESULTS: HDMEC/RASF proliferation was induced by OSM and interleukin-1beta (IL-1beta), alone and in combination. OSM enhanced cell surface expression of ICAM-1, but not VCAM-1, on endothelial cells and RASFs. OSM increased endothelial cell tubule formation and migration. In RA synovial explants, OSM induced production of MMP-1 and TIMP-1. When OSM was combined with IL-1beta, however, the MMP-1:TIMP-1 ratio was significantly increased. OSM potentiated IL-1beta-induced MMP-1 and MMP-13 expression in normal human cartilage/RASF cocultures, resulting in a significant increase in the MMP:TIMP ratio. In OSM/IL-1beta- stimulated cocultures, cartilage sections demonstrated significant proteoglycan depletion that was paralleled by a significant increase in GAG release in supernatants. Finally, compared with either cytokine alone, the combination of OSM and IL-1beta significantly induced VEGF production in RASF/cartilage cocultures.
CONCLUSION: These data suggest that OSM promotes angiogenesis and endothelial cell migration and potentiates the effects of IL-1beta in promoting extracellular matrix turnover and human cartilage degradation. Furthermore, the induction of VEGF in cocultures supports the hypothesis of a link between angiogenesis and cartilage degradation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009243     DOI: 10.1002/art.22161

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  31 in total

1.  Endothelium-derived GM-CSF influences expression of oncostatin M.

Authors:  Wafa M Elbjeirami; Elizabeth M Donnachie; Alan R Burns; C Wayne Smith
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

2.  Oncostatin M reduces lesion size and promotes functional recovery and neurite outgrowth after spinal cord injury.

Authors:  Helena Slaets; Sofie Nelissen; Kris Janssens; Pia M Vidal; Evi Lemmens; Piet Stinissen; Sven Hendrix; Niels Hellings
Journal:  Mol Neurobiol       Date:  2014-07-05       Impact factor: 5.590

Review 3.  New insights in synovial angiogenesis.

Authors:  Zoltán Szekanecz; Timea Besenyei; György Paragh; Alisa E Koch
Journal:  Joint Bone Spine       Date:  2009-12-21       Impact factor: 4.929

4.  Targeting Angiogenesis in Rheumatoid Arthritis.

Authors:  Zoltán Szekanecz; Alisa E Koch
Journal:  Curr Rheumatol Rev       Date:  2008-11-01

5.  Therapeutic effect of dimethyl dimethoxy biphenyl dicarboxylate on collagen-induced arthritis in rats.

Authors:  Roba M Talaat; Amira S Abo-El-Atta; Sabah M Farou; Karima I El-Dosoky
Journal:  Chin J Integr Med       Date:  2014-03-02       Impact factor: 1.978

6.  The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.

Authors:  K Rychli; C Kaun; P J Hohensinner; G Rega; S Pfaffenberger; E Vyskocil; J M Breuss; A Furnkranz; P Uhrin; J Zaujec; A Niessner; G Maurer; K Huber; J Wojta
Journal:  J Thromb Haemost       Date:  2009-12-17       Impact factor: 5.824

Review 7.  Angiogenesis and its targeting in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Alisa E Koch
Journal:  Vascul Pharmacol       Date:  2009-02-13       Impact factor: 5.773

Review 8.  Angiogenesis in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Timea Besenyei; György Paragh; Alisa E Koch
Journal:  Autoimmunity       Date:  2009-11       Impact factor: 2.815

9.  Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis.

Authors:  Tajvur Saber; Douglas J Veale; Emese Balogh; Jennifer McCormick; Sinead NicAnUltaigh; Mary Connolly; Ursula Fearon
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

10.  Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.

Authors:  Ellen M Moran; Ronan Mullan; Jennifer McCormick; Mary Connolly; Owen Sullivan; Oliver Fitzgerald; Barry Bresnihan; Douglas J Veale; Ursula Fearon
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.